Allianz Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-807
Closed -$564K 1853
2020
Q3
$564K Sell
807
-835
-51% -$651K ﹤0.01% 1581
2020
Q2
$1.3M Buy
1,642
+470
+40% +$354K ﹤0.01% 1760
2020
Q1
$698K Sell
1,172
-10
-0.8% -$9.74K ﹤0.01% 1932
2019
Q4
$1.34M Sell
1,182
-1,725
-59% -$1.88M ﹤0.01% 2066
2019
Q3
$3.47M Sell
2,907
-1,903
-40% -$2.91M ﹤0.01% 1605
2019
Q2
$7.93M Sell
4,810
-1,967
-29% -$3.4M 0.01% 1288
2019
Q1
$13.8M Sell
6,777
-323
-5% -$569K 0.01% 954
2018
Q4
$9.08M Sell
7,100
-718
-9% -$1.1M 0.01% 1161
2018
Q3
$14.8M Buy
7,818
+172
+2% +$355K 0.01% 1066
2018
Q2
$15.5M Buy
7,646
+2,791
+57% +$6.36M 0.02% 1019
2018
Q1
$10.7M Buy
4,855
+1,104
+29% +$2.81M 0.01% 1220
2017
Q4
$8.65M Buy
3,751
+2,201
+142% +$4.47M 0.01% 1382
2017
Q3
$2.76M Sell
1,550
-98
-6% -$137K ﹤0.01% 1889
2017
Q2
$2.3M Buy
1,648
+53
+3% +$64K ﹤0.01% 1930
2017
Q1
$1.88M Sell
1,595
-5,564
-78% -$5.68M ﹤0.01% 2019
2016
Q4
$5.72M Sell
7,159
-1,571
-18% -$1.25M 0.01% 1600
2016
Q3
$7.64M Buy
8,730
+7,518
+620% +$5.45M 0.01% 1446
2016
Q2
$679K Hold
1,212
﹤0.01% 2245
2016
Q1
$668K Buy
1,212
+15
+1% +$9.21K ﹤0.01% 2198
2015
Q4
$1M Sell
1,197
-54
-4% -$53.9K ﹤0.01% 1980
2015
Q3
$1.39M Sell
1,251
-766
-38% -$1.4M ﹤0.01% 1710
2015
Q2
$4.4M Sell
2,017
-6,279
-76% -$12.8M ﹤0.01% 1418
2015
Q1
$13M Buy
8,296
+3,707
+81% +$4.89M 0.01% 855
2014
Q4
$5.45M Buy
+4,589
New +$3.07M 0.01% 1185

Other funds holding BLUE

Allianz Asset Management's BLUE Position: Q4 2020 in Review

Allianz Asset Management sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 807 shares — an estimated $564K sold.

Allianz Asset Management first reported a position in BLUE in Q4 2014 and held it in 24 quarters. The position peaked at $15.5M in Q2 2018. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Allianz Asset Management reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • Allianz Asset Management sold 807 bluebird bio shares in Q4 2020, an estimated $564K.
  • Allianz Asset Management first reported a position in bluebird bio in Q4 2014 and held it in 24 quarters.
  • Allianz Asset Management's bluebird bio position peaked at $15.5M in Q2 2018.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Allianz Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.